Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
A Nanotechnology Company Concentrating on Forensics, Security and Counter Terrorism Dr Mike Pitkethly CEO
<ul><li>The Problem </li></ul><ul><li>Most fingerprint powders have a particle size in the order of microns. </li></ul><ul...
<ul><li>The Market </li></ul><ul><li>Forensic powders and chemicals market worth US$800m. Accessible fingerprint powders m...
<ul><li>The  ROAR Proposition </li></ul>
<ul><li>ROAR powders </li></ul><ul><li>ROAR powders and suspensions provide significantly greater sensitivity over current...
Print placed in MALDI-TOF 2  for further interrogation ROAR doped fingerprint powders used to develop fingerprint Lifted p...
<ul><li>Using ROAR powders </li></ul><ul><li>The presence of explosives on a fingerprint can be detected down to nanogram ...
<ul><li>Using ROAR powders </li></ul><ul><li>The fingerprint can be interrogated to identify contact residues with the seb...
<ul><li>The ROAR Advantage </li></ul><ul><li>Using ROAR’s nanoparticles and OEM hardware we can profile a suspect’s or def...
<ul><li>IP Position </li></ul><ul><li>Patents </li></ul><ul><ul><li>Fundamental patents on use of fingerprint powders and ...
<ul><li>Competition </li></ul><ul><li>Market size linked to population, crime rate and technical capability </li></ul><ul>...
<ul><li>Product Entry to Market </li></ul><ul><li>Basic powders and suspensions  </li></ul><ul><ul><li>first sales achieve...
<ul><li>Projected Revenues </li></ul>
<ul><li>Senior Management Team </li></ul><ul><li>ROAR Particles has an successful team </li></ul><ul><li>Mr J Arend </li><...
<ul><li>Financial </li></ul><ul><li>Investment sought £1m </li></ul><ul><li>Investment will be used to:- </li></ul><ul><ul...
www.roarparticles.com
Upcoming SlideShare
Loading in …5
×

Roar presentation to CONNECT North East Conference 09

1,124 views

Published on

ROAR presentation to CONNECT North East Conference 09

Published in: Business, Technology
  • Be the first to comment

Roar presentation to CONNECT North East Conference 09

  1. 1. A Nanotechnology Company Concentrating on Forensics, Security and Counter Terrorism Dr Mike Pitkethly CEO
  2. 2. <ul><li>The Problem </li></ul><ul><li>Most fingerprint powders have a particle size in the order of microns. </li></ul><ul><li>Limited to only defining ridge patterns </li></ul><ul><li>Once the mark is developed, lifted and photographed no more information can be derived. </li></ul><ul><li>Customers include police forces, homeland security, coastguard, immigration, defence, postal services, etc. </li></ul>
  3. 3. <ul><li>The Market </li></ul><ul><li>Forensic powders and chemicals market worth US$800m. Accessible fingerprint powders market worth US$60m </li></ul><ul><li>It is estimated that ROAR should be able to take 10% of the powders market with its enhanced powders. </li></ul><ul><li>There are 400 key US forensic laboratories, a potential market of US$160 million (400 labs x US$400k per machine). ROAR should be able to penetrate 50% of this market. </li></ul><ul><li>Market for analytical services valued conservatively at £10m per year in two years for which ROAR technology would be required. </li></ul>Latent Fingerprint Profiling US$m USA World Powders Tapes & Backing Cards Chemical Supplies 31 83 326 93 249 978 Total 440 1320 OEM Analytical Chromatography & Mass Spectroscopy Instruments Chromatography & Mass Spec troscopy 27 81
  4. 4. <ul><li>The ROAR Proposition </li></ul>
  5. 5. <ul><li>ROAR powders </li></ul><ul><li>ROAR powders and suspensions provide significantly greater sensitivity over current commercial powders. </li></ul><ul><ul><li>fingerprints developed with </li></ul></ul><ul><ul><li>more prints developed, more detail obtained, greater chance of identification </li></ul></ul><ul><ul><li>100x magnification </li></ul></ul>Commercial powder ROAR powder ROAR Suspension
  6. 6. Print placed in MALDI-TOF 2 for further interrogation ROAR doped fingerprint powders used to develop fingerprint Lifted print attached to MALDI-TOF 2 specimen plate Using the ROAR doped powder as a matrix gives rise to characteristic spectra for compounds of interest.
  7. 7. <ul><li>Using ROAR powders </li></ul><ul><li>The presence of explosives on a fingerprint can be detected down to nanogram concentrations. </li></ul>TNT PETN Tetryl (a) 1ug of each test explosive (TNT, tetryl, PETN) was applied over a 1cm 2 area. (b) This equates to 1g of explosives deposited over 100m 2 or 1oz over 15 tennis courts. (c) This area was touched with the tip of a finger which was then touched on a clean surface. (d) The resulting fingerprint was dusted with ROAR CB, lifted and examined by negative ion MALDI-TOF
  8. 8. <ul><li>Using ROAR powders </li></ul><ul><li>The fingerprint can be interrogated to identify contact residues with the sebum of the fingerprint, such as: </li></ul><ul><ul><li>Drugs of abuse </li></ul></ul><ul><ul><li>Nicotine </li></ul></ul><ul><ul><li>(a) TOF-MS trace from addict in contact with cocaine (mass 304.34) compared to drug free print. Mass 304.47 is a commonly occurring constituent of fingerprints. </li></ul></ul><ul><ul><li>(b) CID MSMS of mass 304.34 showing fragmentation pattern unique to cocaine </li></ul></ul>
  9. 9. <ul><li>The ROAR Advantage </li></ul><ul><li>Using ROAR’s nanoparticles and OEM hardware we can profile a suspect’s or defendant’s individual characteristics via one fingerprint analysis, taking less than 5 minutes </li></ul><ul><ul><li>Up to 30% improved sensitivity in fingerprint development </li></ul></ul><ul><ul><li>Ability to detect contact residues the fingerprint donor has/hasn’t been in contact with </li></ul></ul><ul><ul><li>Ability to identify metabolites excreted from the body, i.e. prescription drugs </li></ul></ul><ul><ul><li>Via biomarkers, detect age, gender and ethnicity of the fingerprint donor </li></ul></ul><ul><li>The additional information obtained has a direct link back to suspect or defendant via their fingerprint </li></ul>
  10. 10. <ul><li>IP Position </li></ul><ul><li>Patents </li></ul><ul><ul><li>Fundamental patents on use of fingerprint powders and MS held by ROAR Particles or under licence from Sunderland University </li></ul></ul><ul><ul><li>Nanoparticles as agents for imaging finger prints: </li></ul></ul><ul><ul><li>Doped hydrophobic nano- and micro-particles for latent fingerprints: </li></ul></ul><ul><ul><li>Fingerprint analysis using mass spectrometry: </li></ul></ul><ul><ul><li>Methods of determining properties of latent fingerprints (joint with NTU) </li></ul></ul><ul><ul><li>Identification of sample components </li></ul></ul><ul><li>IP strategy </li></ul><ul><ul><li>Build patent portfolio around core technology and applications </li></ul></ul><ul><ul><li>File national phase patents in key countries in the world e.g. USA, Europe, Japan, India, China, etc. </li></ul></ul><ul><ul><li>Monitor patent filings and new product launches and defend infringements actively </li></ul></ul>
  11. 11. <ul><li>Competition </li></ul><ul><li>Market size linked to population, crime rate and technical capability </li></ul><ul><ul><li>Primary geographic markets - North, Central and South America, Japan, UK and Western Europe, Southern Africa, South East Asia and China. </li></ul></ul><ul><ul><li>Secondary geographic markets - Eastern Europe, Russia, Middle East, India and Australia. </li></ul></ul><ul><li>Competitive products </li></ul><ul><ul><li>Alternative basic powders available </li></ul></ul><ul><ul><li>No equivalent suspensions currently available </li></ul></ul><ul><ul><li>No products capable of use with Mass Spectroscopy </li></ul></ul><ul><li>Competition </li></ul><ul><ul><li>Two primary producers of fingerprint powders, Sirchie and Safariland, based in US </li></ul></ul><ul><ul><li>Numerous smaller producers, principally regionally based e.g. Arrowhead, CSI, PSI </li></ul></ul><ul><ul><li>Numerous forensic products suppliers often selling rebadged products, predominantly nationally based </li></ul></ul><ul><ul><li>Four principle MS suppliers </li></ul></ul>
  12. 12. <ul><li>Product Entry to Market </li></ul><ul><li>Basic powders and suspensions </li></ul><ul><ul><li>first sales achieved, scale-up in progress </li></ul></ul><ul><li>Enhanced powders ( with Lifting tapes and covers) </li></ul><ul><ul><li>contact residues & endogenous compounds– June 2009 </li></ul></ul><ul><ul><li>biomarkers – June 2010 </li></ul></ul><ul><li>Distributors identified for primary geographic markets </li></ul><ul><ul><li>North, Central and South America – term sheet agreed </li></ul></ul><ul><ul><li>Japan – term sheet signed, contract in negotiation </li></ul></ul><ul><ul><li>UK/Europe – term sheet agreed, contract in negotiation </li></ul></ul><ul><ul><li>South Africa – leading distributor engaged in early stage talks </li></ul></ul><ul><li>OEM supply of MALDI-TOF 2 -MS – September 2009 </li></ul><ul><ul><li>Letter of Intent signed, moving to contract negotiation </li></ul></ul><ul><ul><li>Potential US agent identified with first sales targeted for autumn 2009 </li></ul></ul><ul><li>Analysis of enhanced prints, a service provision </li></ul><ul><ul><li>Work initiated to verify concept for an analysis service using the ROAR technology. </li></ul></ul>
  13. 13. <ul><li>Projected Revenues </li></ul>
  14. 14. <ul><li>Senior Management Team </li></ul><ul><li>ROAR Particles has an successful team </li></ul><ul><li>Mr J Arend </li></ul><ul><li>Chairman </li></ul><ul><li>Joe Arend has over 30 years of commercial experience and 15 years experience in building Biotech companies. Mr Arend has been both executive and non-executive director in the start-up and flotation of several biotech companies including Antisoma plc, Osmotech plc, Reflect Technologies plc, Enzacta plc.. </li></ul><ul><li>Professor Frederic Rowell </li></ul><ul><li>Chief Scientific Officer </li></ul><ul><li>Professor Rowell has over 34 years of research and development experience with an emphasis on applications of nanoparticles to forensic analysis. He authored over 100 publications and has generated £2.1 million in research grants. He is currently a visiting Professor at NT University, Singapore. </li></ul><ul><li>Dr Michael Pitkethly </li></ul><ul><li>Chief Executive Officer </li></ul><ul><li>Michael has held a number of senior technical and managerial positions in DERA and then QinetiQ. He was a founding director of QinetiQ Nanomaterials Plc, a wholly owned subsidiary of the QinetiQ Group . He was the CEO of Cenamps in Newcastle focused on developing and commercialising small-scale enabling technologies before joining ROAR. </li></ul>
  15. 15. <ul><li>Financial </li></ul><ul><li>Investment sought £1m </li></ul><ul><li>Investment will be used to:- </li></ul><ul><ul><li>Build-up commercial team </li></ul></ul><ul><ul><li>Expand scale-up capability </li></ul></ul><ul><ul><li>Provide working capital for OEM equipment </li></ul></ul><ul><ul><li>Patent filing and maintenance costs </li></ul></ul><ul><ul><li>Accelerate R&D on biomarkers </li></ul></ul><ul><ul><li>Purchase equipment to enable trials with potential customers using ROAR supplied trial equipment </li></ul></ul><ul><ul><li>Provide working capital for running costs </li></ul></ul>
  16. 16. www.roarparticles.com

×